NCT05954975

Brief Summary

The goal of this prospective single center feasibility study is to assess the feasibility of using BabyCheck and PO by GPs as an illness severity score for young infants \> 6 months of age in order to aid the decision for referral to hospital. The emergency GP posts in Leiderdorp will add the BabyCheck and PO to their standard evaluation of infants presenting with systemic illness \< six months of age for a period of six months. The feasibility will be determined by calculating the percentage of eligible infants in whom a complete BabyCheck score and PO data were retrieved. The investigators consider the protocol feasible if this is done in 80% of all eligible infants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

6 months

First QC Date

June 12, 2023

Last Update Submit

July 18, 2023

Conditions

Keywords

ScreeningBabyCheckPulse oximetryYoung infant

Outcome Measures

Primary Outcomes (1)

  • Feasibility

    Feasibility will be determined by calculating the percentage of eligible infants in whom a complete BabyCheck score and PO data were retrieved. We consider the protocol feasible if this is done in 80% of all eligible infants.

    6 months

Secondary Outcomes (3)

  • Sensitivity and specificity of the combined BabyCheck-PO score

    6 months

  • Acceptability of GPs

    6 months

  • Acceptability of pediatricians

    6 months

Study Arms (1)

Infants up to 6 months of age

Infants up to six months of age, presenting with systemic illness at the emergency GP post.

Combination Product: BabyCheck and pulse oximetry

Interventions

BabyCheck and pulse oximetryCOMBINATION_PRODUCT

The BabyCheck is a validated scoring system to grade the severity of acute systemic illness in infants up to six months of age. Severity of illness is graded by using a weighted score of a combination of nineteen signs and symptoms. The higher the score, the higher the chance of severe illness. Nellcor PM10N is a pulse oximeter which is cleared for use in young infants. A sensor for infants will be used, so reliable oxygen saturation and heart rate can be obtained.

Infants up to 6 months of age

Eligibility Criteria

Age0 Months - 6 Months
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Our study population consists of infants up to six months of age, presenting with systemic (non-traumatic/surgical) illness at the emergency GP post.

You may qualify if:

  • Infants up to six months of age.
  • Presenting with systemic illness (no injuries or traumata).
  • Presenting at the emergency GP post of Leiderdorp.

You may not qualify if:

  • Infants up to six months of age, presenting with traumata or that are in a resuscitation setting.
  • Infants with referral to other hospitals than the Alrijne hospital. The location for referral is coded and available from the anonymized database of the emergency GP post.
  • Infant \< 1 month of age presenting with fever (body temperature \> 38.0 ⁰C), with or without unknown origin, since these infants should always be referred according to the national guidelines for GPs.
  • Infants \< 3 months of age presenting with fever of unknown origin (temperature \> 38.0 ⁰C), since these infants should always be referred according to the national guidelines for GPs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infant, Newborn, Diseases

Interventions

Oximetry

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Blood Gas AnalysisBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Pediatrician and principal investigator Ilona Narayen

Study Record Dates

First Submitted

June 12, 2023

First Posted

July 20, 2023

Study Start

September 1, 2023

Primary Completion

March 1, 2024

Study Completion

May 1, 2024

Last Updated

July 20, 2023

Record last verified: 2023-07